ROSENTHALE MARVIN E 4
4 · NURX PHARMACEUTICALS, INC. · Filed Feb 24, 2010
Insider Transaction Report
Form 4
NURX PHARMACEUTICALS, INC.NUXP.OB
ROSENTHALE MARVIN E
Director
Transactions
- Award
Stock Option (right to buy)
2009-03-06+50,000→ 50,000 totalExercise: $0.45From: 2009-03-06Exp: 2013-10-28→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-03-06−50,000→ 0 totalExercise: $4.00From: 2008-10-28Exp: 2013-10-28→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The reporting person agreed to cancellation of an option granted to him on October 28, 2008 in exchange for a new option having a lower exercise price.